Navigation Links
InspireMD Announces First Quarter 2012 Financial Results
Date:5/8/2012

2; stent provides outstanding and lifelong embolic protection, without affecting deliverability. MGuard™ is CE Mark approved. Mesh-based protection is now recommended for use in the recent Guidelines of the Task force of Myocardial Revascularization of the European Society of Cardiology (ESC).

MGuard™ is currently being investigated in the multi-center international MASTER (MGuard™ for Acute ST Elevation Reperfusion) trial. This study has been designed to evaluate the MGuard™ stent compared to commercially-approved BMS or DES products in STEMI patients undergoing primary angioplasty. Preliminary top line results are expected in the third quarter of 2012. Plans for a registration study in the US are also at an advanced stage.

About InspireMD, Inc.InspireMD is a medical device company focused on the development and commercialization of its proprietary stent system technology, MGuard. InspireMD intends to pursue applications of this technology in coronary, carotid and peripheral artery procedures. InspireMD's common stock is listed on the OTC BB under the ticker symbol "NSPR".

Forward-looking Statements: This press release contains "forward-looking statements." Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative c
'/>"/>

SOURCE InspireMD, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
2. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
3. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
4. InspireMD Boosts MGuard Production Capacity
5. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
6. InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
7. InspireMD Increases Geographic Penetration; MGuard Stent is Now Available in India
8. InspireMD Promotes MGuard™ at the EuroPCR 2011 Exhibition and Conference in Paris This Week
9. InspireMD Announces Year-to-Date 2011 Progress
10. InspireMD Broadens Global Distribution Network; Signs Distributor for the Russian Federation
11. Sol J. Barer, Ph.D. Joins InspireMD Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... , Suisse, October 1, 2014 ... clinique et dans le domaine de l,analyse des ... lancé aujourd,hui une solution de diagnostic in vitro ... une analyse complète de la mucoviscidose dans un ... et de caractériser tous les types de variantes ...
(Date:10/1/2014)... , October 1, 2014 ... Next Generation Sequencing (NGS) data analysis, today launches a ... cystic fibrosis analysis in a single NGS experiment. The ... all types of variants in a single NGS experiment ... it has not been possible to simultaneously analyse all ...
(Date:9/30/2014)... the health and safety of Canadians is our government,s highest priority.  ... tools at its disposal to help ensure that the drugs Canadians ... that end, Health Canada has taken ... of all drug products from three plants in ... Apotex Pharmachem India Pvt Ltd , Apotex Research Private Limited ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Sophia Genetics Launches Full CFTR Analysis in Single Clinical Grade NGS Experiment 2Statement by the Honourable Rona Ambrose on the import ban of drug products from three plants in India 2
... Oct. 20 /PRNewswire-Asia-FirstCall/ -- 3SBio Inc.,(Nasdaq: SSRX ) ... researching, developing, manufacturing and marketing,biopharmaceutical products, today announced the ... October 12, 2009. , At ... and Mr.,Moujia Qi to serve as members of the ...
... used to treat high blood pressure appear to be effective ... stable ischemic heart disease, according to a new comparative effectiveness ... A version of the analysis was posted in the ... Medicine . , Treatment featuring the two medications -- inhibitors ...
Cached Medicine Technology:High Blood Pressure Medicines Show Promise For Treating Heart Disease 2High Blood Pressure Medicines Show Promise For Treating Heart Disease 3
(Date:10/1/2014)... October 01, 2014 After a run ... "Beautiful Births", emerging filmmaker Jacqui Blue is continuing her ... discover the truth about natural birth. The documentary has ... over the world and has been an effective medium ... the topics highlighted in the film provide a wealth ...
(Date:10/1/2014)... This weekend Pope Francis drew world-wide attention ... Speaking to 40,000 seniors in St. Peter's Square in the ... "Violence against the elderly is as inhuman as that ... old people just discarded, victims of an abandonment that is ... throw-away culture that is hurting our world so much," he ...
(Date:10/1/2014)... 2014 The Oliver Law Group ... Other-Sonic Ultrasound Gel lawsuit web page ... litigation surrounding the 2011 Pseudomonas aeruginosa / bacterial ... Oak, Michigan, which was ultimately traced to the ... William Beaumont patients who allegedly became ill following ...
(Date:10/1/2014)... October 01, 2014 Looking for holiday gift ... care, is making gift giving easy this holiday season. Starting ... by Éminence to solve all shopping dilemmas. Choose from two ... ingredients to target the delicate eye area or to deliver ... Set and Eye Rescue Duo Gift Set are formulated to ...
(Date:10/1/2014)... 01, 2014 Indosoft, Inc., a leading provider ... that it has added support for Sangoma Lyra ... Indosoft have a history of bringing innovative products ... technology offers a significant benefit to those using Asterisk as ... now available to users of Q-Suite. , In the past ...
Breaking Medicine News(10 mins):Health News:Filmmaker Jacqui Blue's Beautiful Births Documentary, "Really Touched My Heart" 2Health News:Filmmaker Jacqui Blue's Beautiful Births Documentary, "Really Touched My Heart" 3Health News:Filmmaker Jacqui Blue's Beautiful Births Documentary, "Really Touched My Heart" 4Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 2Health News:Pope Francis Shines New Spotlight on Neglect of Elderly, Survey Finds Elder Self-Neglect is a Growing and Hidden Problem in U.S. says NAPGCM 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 4Health News:Éminence Organic Skin Care Launches Limited Edition Spa Gift Sets for the Holiday Season 2Health News:Éminence Organic Skin Care Launches Limited Edition Spa Gift Sets for the Holiday Season 3Health News:Indosoft Announces Q-Suite Support For Sangoma Lyra 2
... One-fourth of overweight children may have sleep problems that ... ,Research published in the November issue of Obesity ... children tested positive for sleep-disordered breathing, including telltale snoring. ... after-school physical activity such as jumping rope, basketball and ...
... a dearth of specialists, which was confirmed by the Hospital ... the hospital will have to put up with the shortfall ... services is currently on leave. The hospital is in the ... , ,The medical board is also ...
... and cynical exploitation” by the alternative medicines industry, argues a ... estimated that up to 80% of all patients with cancer ... help treat their cancer, writes Jonathan Waxman, Professor of Oncology ... the use of many of these approaches is obtuse – ...
... study on schizophrenic patients has come up with a finding ... anti-psychotic drugs. // ,The study was conducted upon ... the treatment they were getting was ineffective. They were then ... on new. Experienced doctors decided which type of anti–psychotic drug ...
... examination of 4 cases of botulism following cosmetic injections ... highly concentrated, //unlicensed preparation that resulted in toxin levels ... according to a report. ,Botulism is a rare ... bacterium Clostridium botulinum and toxin-producing strains of Clostridium baratii ...
... in on cardiac master cells that could develop into ... groups of researchers who have been putting their independent ... teams from Massachusetts General Hospital have recognized a variety ... this could develop into cardiac muscle, endothelial cells or ...
Cached Medicine News:Health News:Sleep Problems in Overweight Children Appear Fairly Common 2Health News:Sleep Problems in Overweight Children Appear Fairly Common 3Health News:Protect Patients from Exploitation by Alternative Medicines Industry, Says Expert 2Health News:Old Anti-psychotic Drugs Are Equally Good 2Health News:Highly-Concentrated Botulinum Preparation Can Result in Severe Illness 2Health News:Highly-Concentrated Botulinum Preparation Can Result in Severe Illness 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: